La Rosa Holdings Corp. Reports 31% Annualized Rate Reduction in Technology Costs in 2025 compared to 2022 Through Proprietary Platform Strategy

La Rosa Holdings Corp. Reports 31% Annualized Rate Reduction in Technology Costs in 2025 compared to 2022 Through Proprietary Platform Strategy GlobeNewswire December 22, 2025 Celebration, FL, Dec. 22, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced a 31% annualized […]

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112(TM)) in Autoimmune Diseases and Hematologic Malignancies

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112(TM)) in Autoimmune Diseases and Hematologic Malignancies GlobeNewswire December 22, 2025 -Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy data suggest significant clinical improvement in patients dosed at the 100 million cell dose, with the

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways GlobeNewswire December 22, 2025 PISCATAWAY, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — The DALI Alliance, recognized as the international authority in lighting technology standardization, proudly announces the launch of its new test and certification specifications for Wireless to DALI Gateways. This groundbreaking release

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) Novel PTH analog achieves sustained calcium elevation for >3 days from single oral tablet, supporting development path toward once-daily alternative to daily injections GlobeNewswire December 22, 2025 JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE)

KULR Technology Group Announces Six-Month Pause on At-the-Market Equity Offering Program

KULR Technology Group Announces Six-Month Pause on At-the-Market Equity Offering Program GlobeNewswire December 22, 2025 HOUSTON , Dec. 22, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), an energy-systems platform company that enables the safe, certifiable deployment of ultra-high-power lithium battery systems for space and defense programs, hyperscale

EdgeMode Secure Strategic Power Milestone for Europe’s Largest AI Data Center Pipeline

EdgeMode Secure Strategic Power Milestone for Europe's Largest AI Data Center Pipeline GlobeNewswire December 22, 2025 FORT LAUDERDALE, Fla., Dec. 22, 2025 (GLOBE NEWSWIRE) — EdgeMode (OTC: EDGM), a global Energy and AI data center infrastructure company, in a joint venture with Blackberry Alternative Investment Fund (BAIF), has announced a major operational milestone in the

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program A Total of ~11,500 Metres of Drilling Planned as Part of Substantial 2026 Exploration Budget Prioritized for Discovery GlobeNewswire December 22, 2025 VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to

FLINT Secures $451 million in New Contract Awards and Renewals

FLINT Secures $451 million in New Contract Awards and Renewals GlobeNewswire December 22, 2025 CALGARY, Alberta, Dec. 22, 2025 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company“) (TSX: FLNT) is pleased to announce that since the release of its third quarter results and the press release of October 28, 2025 announcing new contract awards

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 22, 2025 MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at

Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference

Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 22, 2025 DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) — Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial

Scroll to Top